Advertisement

Supportive Care in Cancer

, Volume 27, Issue 5, pp 1591–1600 | Cite as

Examining the “usual” in usual care: a critical review and recommendations for usual care conditions in psycho-oncology

  • Joanna J. ArchEmail author
  • Annette L. Stanton
Review Article
  • 95 Downloads

Abstract

Purpose

Within psycho-oncology clinical trials, usual care (UC) represents a common and important control condition. Yet recent shifts in oncology, coupled with insufficient description of such conditions, threaten to render UC increasingly difficult to define and interpret. This paper offers evidence of these shifts and recommendations for addressing them.

Methods

The broader literature on usual care as a control condition in psychosocial/behavioral intervention trials was assessed, and usual care-controlled trials in psycho-oncology were selectively reviewed, toward to goal of conceptual synthesis.

Results

We offer evidence that (1) UC control conditions are often insufficiently defined and assessed; and (2) the context of supportive care in oncology has shifted in a manner that contributes to this problem, with implications for interpreting and comparing findings across clinical trials. Three converging findings support these conclusions. First, the scientific literature increasingly documents the diversity in how “usual care” conditions are defined across psychosocial and behavioral trials, with important considerations for trial interpretation. Second, evidence suggests that the availability of psychosocial oncology care has increased over the past few decades. The increasing availability and variety of psychosocial care introduces potential confounds for UC conditions. Third, mental health care trends in the general population affect the supportive interventions available to oncology patients in UC conditions today versus in the past.

Conclusions

Shifts in psychosocial oncology and broader mental health care underscore the importance of carefully defining and assessing UC in psycho-oncology trials. Recommendations are offered for improving the design, evaluation, and interpretation of UC conditions, toward the ultimate goal of improving the quality of the evidence in psycho-oncology.

Keywords

Psycho-oncology Supportive care Cancer Usual care Control group Randomized trial 

Notes

Funding

J.J.A was supported by the American Cancer Society Research Scholar Grant (Arch, RSG-15-020-01–CPPB) and Pilot & Exploratory Palliative Care Grant (Arch, PEP-16-055-01) in preparing this manuscript; A.L.S. was supported by the Breast Cancer Research Foundation (Stanton, BCRF-20184915).

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interest. The authors maintained full control and responsibility for the content and primary data connected to this manuscript. We agree to allow the journal to review our data if requested.

References

  1. 1.
    Jacobsen PB, Holland JC, Steensma DP (2012) Caring for the whole patient: the science of psychosocial care. J Clin Oncol 30(11):1151–1153CrossRefGoogle Scholar
  2. 2.
    American College of Surgeons: Commission on Cancer (2012) Cancer program standards 2012: ensuring patient-centered care. vol v1.2.1, ChicagoGoogle Scholar
  3. 3.
    Bultz BD, Groff SL, Fitch M, Blais MC, Howes J, Levy K, Mayer C (2011) Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psycho-Oncology 20(5):463–469CrossRefGoogle Scholar
  4. 4.
    Accreditation Canada (2008) Cancer care and oncology services standards. https://accreditation.ca/accreditation/. Accessed 18 Dec 2018
  5. 5.
    Deshields T, Kracen A, Nanna S, Kimbro L (2016) Psychosocial staffing at National Comprehensive Cancer Network member institutions: data from leading cancer centers. Psycho-Oncology 25(2):164–169CrossRefGoogle Scholar
  6. 6.
    Deshields T, Zebrack B, Kennedy V (2013) The state of psychosocial services in cancer care in the United States. Psycho-Oncology 22(3):699–703CrossRefGoogle Scholar
  7. 7.
    Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH (2011) Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev 20(10):1996–2005CrossRefGoogle Scholar
  8. 8.
    De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E (2014) Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 15(1):23–34CrossRefGoogle Scholar
  9. 9.
    Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, Bannon F, Ahn JV, Johnson CJ, Bonaventure A (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefGoogle Scholar
  10. 10.
    Institute of Medicine (2008) Cancer care for the whole patient: meeting psychosocial health needs. National US Academies Press, Washington, DCGoogle Scholar
  11. 11.
    Institute of Medicine (2006) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DCGoogle Scholar
  12. 12.
    Rowland JH, Kent EE, Forsythe LP, Loge JH, Hjorth L, Glaser A, Mattioli V, Fosså SD (2013) Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer 119:2094–2108CrossRefGoogle Scholar
  13. 13.
    Areán PA, Alvidrez J (2002) Ethical considerations in psychotherapy effectiveness research: choosing the comparison group. Ethics Behav 12(1):63–73CrossRefGoogle Scholar
  14. 14.
    Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, Ockene J, Kaplan R (2009) The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom 78(5):275–284CrossRefGoogle Scholar
  15. 15.
    Kazdin AE (2015) Treatment as usual and routine care in research and clinical practice. Clin Psychol Rev 42:168–178CrossRefGoogle Scholar
  16. 16.
    Garland AF, Hurlburt MS, Brookman-Frazee L, Taylor RM, Accurso EC (2010) Methodological challenges of characterizing usual care psychotherapeutic practice. Adm Policy Ment Health Ment Health Serv Res 37(3):208–220CrossRefGoogle Scholar
  17. 17.
    Freedland KE, Mohr DC, Davidson KW, Schwartz JE (2011) Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med 73(4):323–335CrossRefGoogle Scholar
  18. 18.
    Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, Otte C (2017) Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry 4(9):725–732CrossRefGoogle Scholar
  19. 19.
    Mohr DC, Ho J, Hart TL, Baron KG, Berendsen M, Beckner V, Cai X, Cuijpers P, Spring B, Kinsinger SW (2014) Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Transl Behav Med 4(4):407–423CrossRefGoogle Scholar
  20. 20.
    Wells KB (1999) Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatr 156(1):5–10CrossRefGoogle Scholar
  21. 21.
    McGuire TG, Miranda J (2008) New evidence regarding racial and ethnic disparities in mental health: policy implications. Health Aff 27(2):393–403CrossRefGoogle Scholar
  22. 22.
    Nelson A (2002) Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc 94(8):666Google Scholar
  23. 23.
    Stanciole AE, Huber M (2009) Access to health care for migrants, ethnic minorities, and asylum seekers in Europe. Policy Brief European Centre for Social Welfare Policy and Research: 1–8Google Scholar
  24. 24.
    Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ (2012) Metastatic breast cancer, version 1.2012 featured updates to the NCCN guidelines. J Natl Compr Cancer Netw 10(7):821–829CrossRefGoogle Scholar
  25. 25.
    Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, Cardoso F, Group EGW (2013) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(suppl_6):vi7–vi23Google Scholar
  26. 26.
    National Comprehensive Cancer Network (2018) Distess management (guidelines version 2.2018). https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf. Accessed 15 Aug 2018
  27. 27.
    Rayner L, Price A, Hotopf M, Higginson IJ (2011) The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 47(5):702–712CrossRefGoogle Scholar
  28. 28.
    Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF (2012) Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol 30(11):1197–1205CrossRefGoogle Scholar
  29. 29.
    Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, Holland JC, Partridge AH, Bak K, Somerfield MR, Rowland JH (2014) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32(15):1605–1620CrossRefGoogle Scholar
  30. 30.
    Institute of Medicine (2001) Crossing the quality chasm: a new health system for the 21st century. National Academy Press, Washington, DCGoogle Scholar
  31. 31.
    Hewitt M, Simone J (1999) Institute of Medicine Report: ensuring quality cancer care. National Academy Press, Washington, DCGoogle Scholar
  32. 32.
    Coluzzi PH, Grant M, Doroshow JH, Rhiner M, Ferrell B, Rivera L (1995) Survey of the provision of supportive care services at National Cancer Institute-designated cancer centers. J Clin Oncol 13(3):756–764CrossRefGoogle Scholar
  33. 33.
    Stone AA, Schwartz JE, Neale JM, Shiffman S, Marco CA, Hickcox M, Paty J, Porter LS, Cruise LJ (1998) A comparison of coping assessed by ecological momentary assessment and retrospective recall. J Pers Soc Psychol 74(6):1670–1680CrossRefGoogle Scholar
  34. 34.
    Hellbom M, Bergelt C, Bergenmar M, Gijsen B, Loge JH, Rautalathi M, Smaradottir A, Johansen C (2011) Cancer rehabilitation: a Nordic and European perspective. Acta Oncol 50(2):179–186CrossRefGoogle Scholar
  35. 35.
    Owen JE, Goldstein MS, Lee JH, Breen N, Rowland JH (2007) Use of health-related and cancer-specific support groups among adult cancer survivors. Cancer 109(12):2580–2589CrossRefGoogle Scholar
  36. 36.
    Hewitt M, Rowland JH (2002) Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol 20(23):4581–4590CrossRefGoogle Scholar
  37. 37.
    Nakash O, Levav I, Aguilar-Gaxiola S, Alonso J, Andrade LH, Angermeyer MC, Bruffaerts R, Caldas-de-Almeida JM, Florescu S, De Girolamo G (2014) Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys. Psycho-Oncology 23(1):40–51CrossRefGoogle Scholar
  38. 38.
    McAlpine H, Joubert L, Martin-Sanchez F, Merolli M, Drummond KJ (2015) A systematic review of types and efficacy of online interventions for cancer patients. Patient Educ Couns 98(3):283–295CrossRefGoogle Scholar
  39. 39.
    Pietrangelo A, Akers W (2017) The 2017 State of Cancer Report: the impact of digital information and patient support networks. https://www.healthline.com/health/state-of-cancer. Accessed 20 Aug 2018
  40. 40.
    Bender JL, Jimenez-Marroquin MC, Ferris LE, Katz J, Jadad AR (2013) Online communities for breast cancer survivors: a review and analysis of their characteristics and levels of use. Support Care Cancer 21(5):1253–1263CrossRefGoogle Scholar
  41. 41.
    Mojtabai R (2007) Americans’ attitudes toward mental health treatment seeking: 1990–2003. Psychiatr Serv 58(5):642–651CrossRefGoogle Scholar
  42. 42.
    Mojtabai R (2009) Americans’ attitudes toward psychiatric medications: 1998–2006. Psychiatr Serv 60(8):1015–1023CrossRefGoogle Scholar
  43. 43.
    Olfson M, Marcus SC (2010) National trends in outpatient psychotherapy. Am J Psychiatr 167:1456–1463CrossRefGoogle Scholar
  44. 44.
    Zuvekas SH (2001) Trends in mental health services use and spending, 1987–1996. Health Aff 20(2):214–224CrossRefGoogle Scholar
  45. 45.
    Scheffler RM, Hinshaw SP, Modrek S, Levine P (2007) The global market for ADHD medications. Health Aff 26(2):450–457CrossRefGoogle Scholar
  46. 46.
    Hollingworth SA, Burgess PM, Whiteford HA (2010) Affective and anxiety disorders: prevalence, treatment and antidepressant medication use. Aust N Z J Psychiatry 44(6):513–519Google Scholar
  47. 47.
    Abbing-Karahagopian V, Huerta C, Souverein P, De Abajo F, Leufkens H, Slattery J, Alvarez Y, Miret M, Gil M, Oliva B (2014) Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol 70(7):849–857CrossRefGoogle Scholar
  48. 48.
    Arch JJ, Vanderkruik R, Kirk A, Carr AL (2018) A closer lens: cancer survivors' supportive intervention preferences and interventions received. Psycho-Oncology 27(5):1434–1441CrossRefGoogle Scholar
  49. 49.
    Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E, Speca M (2013) Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer (MINDSET). J Clin Oncol 31(25):3119–3126Google Scholar
  50. 50.
    van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J (2017) Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol 35(19):2173–2183CrossRefGoogle Scholar
  51. 51.
    Penedo FJ, Molton I, Dahn J, Shen B-J, Kinsinger D, Traeger L, Siegel S, Schneiderman N, Antoni MH (2006) A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann Behav Med 31(3):261–270CrossRefGoogle Scholar
  52. 52.
    Hawkes AL, Chambers SK, Pakenham KI, Patrao TA, Baade PD, Lynch BM, Aitken JF, Meng X, Courneya KS (2013) Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J Clin Oncol 31(18):2313–2321CrossRefGoogle Scholar
  53. 53.
    Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280(18):1569–1575CrossRefGoogle Scholar
  54. 54.
    Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children; United States, 2007. National health statistics reports, no. 12. National Center for Health Statistics, HyattsvilleGoogle Scholar
  55. 55.
    Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203CrossRefGoogle Scholar
  56. 56.
    Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS (2008) Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 300(17):2003–2011CrossRefGoogle Scholar
  57. 57.
    Butler G, Fennell M, Robson P, Gelder M (1991) Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol 59(1):167–175CrossRefGoogle Scholar
  58. 58.
    Heldt E, Manfro GG, Kipper L, Blaya C, Maltz S, Isolan L, Hirakata VN, Otto MW (2003) Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital. Psychother Psychosom 72(1):43–48CrossRefGoogle Scholar
  59. 59.
    Ferguson JM (2001) SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 3(1):22–27CrossRefGoogle Scholar
  60. 60.
    Barnes TR, McPhillips MA (1999) Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. Br J Psychiatry 174(S38):34–43CrossRefGoogle Scholar
  61. 61.
    Olfson M, Blanco C, Liu S-M, Wang S, Correll CU (2012) National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry 69(12):1247–1256CrossRefGoogle Scholar
  62. 62.
    Freedland KE, King AC, Ambrosius WT, Mayo-Wilson E, Mohr DC, Czajkowski SM, Thabane L, Collins LM, Rebok GW, Treweek SP, Cook TD, Edinger JD, Stoney CM, Campo RA, Young-Hyman D, Riley WT, for the National Institutes of Health Office of Behavioral and Social Science Research Expert Panel on Comparator Selection in Behavioral and Social Science Clinical Trials (in press) Summary Report: The Selection of Comparators for Randomized Controlled Trials of Health-Related Behavioral Interventions: Recommendations of an NIH Expert PanelGoogle Scholar
  63. 63.
    Wethington E, Kessler RC (1986) Perceived support, received support, and adjustment to stressful life events. J Health Soc Behav 27:78–89CrossRefGoogle Scholar
  64. 64.
    Osborn RL, Demoncada AC, Feuerstein M (2006) Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 36(1):13–34CrossRefGoogle Scholar
  65. 65.
    Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, Steel JL, Cuijpers P, Mohr DC, Berendsen M (2012) Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst 104(13):990–1004CrossRefGoogle Scholar
  66. 66.
    Gorin SS, Krebs P, Badr H, Janke EA, Jim H, Spring B, Jacobsen P (2012) Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol 30(5):539–547CrossRefGoogle Scholar
  67. 67.
    Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 27:20–28CrossRefGoogle Scholar
  68. 68.
    Badr H, Krebs P (2013) A systematic review and meta-analysis of psychosocial interventions for couples coping with cancer. Psycho-Oncology 22(8):1688–1704CrossRefGoogle Scholar
  69. 69.
    Schneider S, Moyer A, Knapp-Oliver S, Sohl S, Cannella D, Targhetta V (2010) Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med 33(1):1–20CrossRefGoogle Scholar
  70. 70.
    Tatrow K, Montgomery GH (2006) Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med 29(1):17–27CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Psychology and NeuroscienceUniversity of Colorado BoulderBoulderUSA
  2. 2.Division of Cancer Prevention and ControlUniversity of Colorado Cancer CenterAuroraUSA
  3. 3.Department of PsychologyUniversity of California Los AngelesLos AngelesUSA
  4. 4.Department of Psychiatry and Biobehavioral SciencesUniversity of California Los AngelesLos AngelesUSA
  5. 5.Jonsson Comprehensive Cancer CenterUniversity of California Los AngelesLos AngelesUSA
  6. 6.Cousins Center for PsychoneuroimmunologyUCLA Semel Institute for NeuroscienceLos AngelesUSA

Personalised recommendations